SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-035477
Filing Date
2022-12-14
Accepted
2022-12-14 19:21:31
Documents
1
Period of Report
2022-12-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 13731
  Complete submission text file 0001493152-22-035477.txt   15848
Mailing Address C/O SEELOS THERAPEUTICS, INC. 300 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address
O'Connor Daniel J. (Reporting) CIK: 0001376847 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41184 | Film No.: 221463393

Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Issuer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 SOMERSET CORPORATE BLVD. 2ND FLOOR BRIDGEWATER NJ 08807
Business Address 100 SOMERSET CORPORATE BLVD. 2ND FLOOR BRIDGEWATER NJ 08807 609-310-0772
Larkspur Health LLC (Reporting) CIK: 0001915818 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41184 | Film No.: 221463392